Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Satsuma Pharmaceuticals, Inc. (STSA)
|
Add to portfolio |
|
|
Price: |
$32.19
| | Metrics |
OS: |
33.2
|
M
| |
|
|
Market cap: |
$1.07
|
B
| |
|
|
Net cash:
|
$41.4
|
M
| |
$1.25
|
per share
|
EV:
|
$1.03
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($60.6)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Research and development | 37.6 | 36.3 | 24.2 | 6.4 | 4.2 |
General and administrative | 13.5 | 12.1 | 4.7 | 1.1 | 0.8 |
EBIT | -51.2 | -48.3 | -28.9 | -7.5 | -4.9 |
Pre-tax income | -51.2 | -47.6 | -28.2 | -7.3 | -5.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | | | |
Net income | -51.2 | -47.6 | -28.2 | -7.3 | -5.2 |
|
Diluted EPS | ($1.75) | ($2.73) | ($4.80) | ($7.15) | ($9.26) |
Shares outstanding (diluted) | 29.2 | 17.4 | 5.9 | 1.0 | 0.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|